A clinical and histologic comparison of electrosurgical and carbon dioxide laser peels - 02/09/11
Abstract |
Background: A radiofrequency-controlled electrosurgical device (ESD) has been adapted for skin peeling. A high-voltage, low-amperage current converts an irrigant into an ionized vapor, causing molecular dissociation and superficial damage in adjacent tissue. Objective: We compared the clinical and histologic effects of a scanning carbon dioxide (CO2) laser (ESC/Sharplan 40C) and the ESD (Visage Cosmetic Surgery System, Arthrocare). Methods: This study was a matched clinical trial involving 9 subjects. Two strips (2 × 1 cm) of skin on the temple were alternately assigned to receive 2 passes with either the CO2 laser (Silktouch mode, 260 handpiece, fluence 15 J/cm2, 10 mm2) or the ESD (125 V = setting 4, 5 mm handpiece). Strips were wiped with moist gauze after the first pass, and 4-mm punch biopsy specimens were taken immediately and after 3 months. Clinical assessment of re-epithelialization, erythema, and hyperpigmentation was made at 1, 2, 4, and 12 weeks. Results: Median erythema scores were significantly greater in skin treated with the CO2 laser. Histologic examination showed greater epidermal loss and a significantly thicker zone of underlying thermal damage (average difference, 63 μm; 95% confidence interval, 40-87; P = .0002) in skin treated with the CO2 laser compared with skin treated with the ESD. After 3 months, a band of superficial dermal fibrosis was thicker in skin treated with the CO2 laser (average difference, 170 μm; 95% confidence interval, 69-271; P = .0075). Conclusion: Two passes with the ESD elicited a more superficial skin peel than the CO2 laser. Despite minimal thermal damage, superficial dermal fibrosis was seen at 3 months in skin treated with the ESD. (J Am Acad Dermatol 2001;44:492-6.)
Le texte complet de cet article est disponible en PDF.Plan
Supported by a research grant from Arthrocare. |
|
Reprint requests: K. M. Acland, Dermatological Surgery and Laser Unit, St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Rd, London SE1 7EH, UK. |
Vol 44 - N° 3
P. 492-496 - mars 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?